Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 1 study of BTM-3566 in patients with B-cell hematological malignancies

Next Previous
X
Search
Trial Profile

A phase 1 study of BTM-3566 in patients with B-cell hematological malignancies

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 13 Jan 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BTM-3566 (Primary)
  • Indications B-cell leukaemia; Diffuse large B cell lymphoma; Haematological malignancies
  • Focus Adverse reactions; First in man; Proof of concept

    • Most Recent Events

    • 09 Jan 2023 According to Bantam Pharma media release, the company has cleared the FDA clearance for Investigational New Drug (IND) BTM-3566.
    • 23 Jun 2022 According to a Bantam Pharmaceutical media release, trial expected to initiate in the fall of 2022.
    • 08 Apr 2022 According to a Bantam Pharmaceutical media release, the company expect to file an Investigational New Drug (IND) application for BTM-3566 this quarter (2Q 2022) and are prepared to initiate clinical trials later this year.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top